Because of the potential importance of interleukin 1 (IL-i) in modulating inflammation and the observations that human blood neutrophils (PMN) express IL-1 receptors (IL-IR) and synthesize IL-la and IL-1j6, we studied the IL-lR on blood PMN from a group of patients with the sepsis syndrome. We report a marked enhancement in the sites per cell of IL-lR expressed on sepsis-PMN of 25 consecutively studied patients compared to 20 controls (patient mean = 9,329±2,212 SE; control mean = 716±42 SE, respectively). There was no demonstrable difference in the Kd of IL-lR on sepsis-PMN (-1 nM) as determined by saturation curves of '25I-L-la binding and the IL-IR on sepsis-PMN had an apparent M, -68,000, a value like that of normal PMN. Cytofluorographic analysis indicated that the sepsis-PMN phenotype is a single homogeneous population with respect to ILIrR expression. In contrast, expression of the membrane complement receptor CR3 is not increased on sepsis-PMN. Similar increases in expression of ILIR were not observed in various other inflammatory processes, including acute disseminated inflammation and organ failure not caused by infection, acute infection without organ failure, and immunopathologies such as active systemic lupus erythematosus and rheumatoid arthritis. Enhanced expression of IL-IR was not related simply to the state of myeloid stimulation. Increased expression of IL-IR on normal PMN was induced in vitro by incubating cells with recombinant human granulocytemacrophage/colony-stimulating factor for 18 h and this response was inhibited by cycloheximide, suggesting the possibility that de novo synthesis of IL-IR might occur in PMN during the sepsis syndrome. (J. Clin.
Introduction
Interleukin-1 (IL-1) occurs as a and ,3 polypeptides that activate specific receptors for IL-I (IL-IR)' (reviewed in reference 1. Abbreviations used in this paper: GM-CSF, granulocyte-macrophage/colony-stimulating factor; IL-2R, IL-2 receptor(s); rhIL-l, recombinant human IL-1; TNFa, tumor necrosis factor-a. 1). IL-I exerts a wide range of biological effects on many cells. As a mediator ofinflammation and host responses to infection, IL-I has effects on thermoregulation, lymphocyte function, synthesis of acute phase proteins, production of arachidonic acid metabolites, granulocytosis, carbohydrate, and protein and lipid metabolism (2) (3) (4) . The importance ofIL-I and tumor necrosis factor-a (TNFa) in the sepsis syndrome has recently been documented (5, 6) , making the characterization of the IL-IR of prime importance. Recently, we (7) and others (8) reported that a single class of high-affinity IL (9) (10) (11) (12) but similar in size to the IL-IR of B-cells and monocytes (13) (14) (15) .
Detectable levels of circulating TNFa and IL-I occur in serum during sepsis in humans (5, 6) and both of these cytokines can mimic the sepsis syndrome in experimental animals (16) (17) (18) . Children with severe meningococcemia and other forms ofsepsis have elevated levels ofTNFa and IL-I in serum and the quantity of these circulating cytokines may correlate with the severity of the disease (5, 6) .
We recently reported that normal human blood PMN synthesize IL-1I,and IL-Ia in response to endotoxin or IL-I itself (19) . Synthesis of IL-1( by human PMN predominates over that of IL-Ia and IL-1(, but little IL-Ia is secreted by these cells. Because of the potential importance of IL-I in the sepsis syndrome, we studied the expression ofIL-I R on human blood PMN obtained from patients with this highly lethal disseminated inflammatory process. We report that sepsis-PMN consistently express a marked increase in the number of IL-I R without a change in Kd (apparent Mr -68,000). The Internalization ofhuman '25I-IL-la in human PMN. 2 X 10'PMN were incubated with 5 X 10-10 M 1251-IL-la for 1 h at 4°C in the presence and absence of a 100-fold excess of unlabeled rhIL-Ia. Cells were washed twice in the binding medium to remove unbound IL-I a and then placed at 37°C. Aliquots were removed at the indicated times, centrifuged, and resuspended in 50 mM glycine-HCl buffer (pH 3) containing 150 mM NaCl for 5 min at 4°C. The cells were then separated from the buffer and released IL-I was separated by centrifugation through silicone oil. Cell pellet and supernatant were recovered and counted.
Receptor sizing. PMN (2 X 107 cells) from patients and controls were incubated with 5 x 10-10 M 1251-IL-la in the presence or absence of 100-fold excess of unlabeled protein for 1 h at 40C. The cells were then washed twice with ice-cold phosphate-buffered saline (PBS) containing 1 mM MgCl at pH 8.5 and then incubated at room temperature for 30 min with 0.15 mg/ml of the homobifunctional cross-linker, disuccidimidyl suberate (Pierce Chemical Co., Rockford, IL). The cells were then washed twice in PBS-1 mM MgC1 at pH 8.5 buffer. After centrifugation, the entire cell pellet was resuspended in 10% SDS in 0.06 M Tris, pH 6.8, boiled for 2 min, and then centrifuged again. The cell supernatants were then stored overnight at -20'C. The following day the samples were suspended in 10% volume of treatment buffer containing 4% SDS in 0.06 M Tris buffer with glycerol and bromophenol blue, pH 6.8, in the presence or absence of 2-fl-mercaptoethanol and boiled for an additional 2 min before being subjected to electrophoresis on a 7.5% polyacrylamide gel. Gels were then dried and exposed to film for up to 
Results
Enhanced expression ofthe IL-IR on PMNfrom septicpatients analyzed by '25I-IL-JIa saturation curves. The number ofIL-I R sites per cell on human PMN from healthy volunteers and patients with the sepsis syndrome was quantitated using 125i-IL-I binding studies and Scatchard analysis of saturation curves. 25 patients and 20 normal controls were studied. Normal PMN had -700 IL-IR per cell with a Kd of -1.4 nM ( Fig. 1 ), a finding similar to that reported by Rhyne et al. (7) and Paganelli-Parker et al. (8) . erythematosus (n = 2) or rheumatoid arthritis (n = 2) but without infection or fever had a mean of236±86 SD IL-I R per cell, a value significantly lower than that of normal PMN (P = < 0.01); (c) no patient in any group exceeded 2,100 IL-IR sites per PMN of IL-I R, a value below the lowest value of the range of IL-1R observed on sepsis-PMN. One of the two patients with acute granulocytic leukemia (untreated and with 20% blast forms and < 10% mature PMN) had a low number of IL-IR (109 sites per PMN).
Internalization of'25-IL-I on sepsis-PMN. Fig. 3 shows the rate of internalization of '25IL-Il bound to sepsis-PMN. 50% internalization of ligand was observed by 30 min, a value like that we reported for normal PMN (7).
Effects ofgranulocyte-macrophage/colony-stimulatingfactor (GM-CSF) on IL-IR expression on normal PMN. Since myeloid stimulation per se did not appear to be responsible for increased expression of IL-l R on sepsis-PMN and the rate of internalization of 1251-IL-I a (and presumably IL-1 R) was normal, we wondered whether normal blood PMN are capable of increasing the expression ofIL-I R in vitro. PMN isolated from venous blood from healthy volunteers (n = 4) were incubated for 18 h at 4VC or 370C with or without 100 U/ml ofrecombi- nant human GM-CSF (rhGM-CSF) (Cistron Corp, Pine Brook, NJ) and analyzed for binding of 25.I-IL-I a. As shown in Fig. 4 A, PMN incubated at 370C for 18 h without rhGM-CSF had reduced specific binding of 25I-IL-la when compared with a 4VC control. In contrast, PMN incubated with rhGM-CSF had an increase in specific binding at 18 h (P < 0.01), and this increase could be almost totally inhibited by 5 gg/ml of cycloheximide, suggesting that synthesis of IL-IR occurred rather than alterations in recycling of previously synthesized receptors. Shown in Fig. 4 B is a Scatchard analysis. There was an increase in IL-I R induced by rhGM-CSF from 400 IL-I R sites per cell in control PMN held at 4VC for 18 h to -800 sites per cell ofIL-I R in PMN treated with rhGM-CSF for 18 h at 370C; no change in Kd occurred. In this experiment, no specific binding was detected in the PMN incubated without rhGM-CSF for 18 h at 370C.
Cytofluorographic analysis of IL-IR and CR3 expression on sepsis-PMN. Enhanced expression of the complement receptor CR3 on human blood PMN has been reported after burn injuries (22, 23) and in vitro after warming of cells to 370C (24) . To determine if increased expression of IL-IR is accompanied by an increase in CR3 expression, or if receptor up-regulation on sepsis-PMN is unimodal, we used flow cytometry to simultaneously analyze both CR3 and IL-I R on PMN from three septic patients and three controls. A unimodal increase in expression of IL-1R was observed on sepsis-PMN vs. normal PMN (Fig. 5 A) . In contrast, no increase in the expression of CR3 was observed on sepsis-PMN with increases in expression of IL-I R (Fig. 5 B) . As a further control, we determined that the antibody to the CD1 lb y chain of CR3 could detect upregulation of CR3 on normal PMN stimulated by either N-formyl-methionyl-leucyl-phenylalanine or bacterial lipopolysaccharide (not shown).
An increased quantity ofthe low molecular weight form of IL-JR is expressed on sepsis-PMN. The size of the IL-I R was evaluated on PMN from three patients with the sepsis syndrome and three controls using crosslinking, solubilization, and electrophoresis. In all instances, a major band was observed with an apparent Mr of -68,000 when corrected for bound IL-la. An example is shown in Fig. 6 . The bands observed were similar in M, to those observed on normal PMN, but were of much stronger intensity in patients (C) than in controls (A). Bands with a higher M, were always seen, perhaps representing aggregated IL-1R or IL-IR associated with other cellular proteins; lower Mr bands were not always detected and could represent proteolytic cleavage or a different species of IL-1R. Precise loading ofa single lane was impossible so "overflow" of bands into adjacent lanes could not be avoided. All cross-linked bands could be completed by unlabeled IL-Ia (B and D). Discussion PMN obtained from the peripheral blood of patients with the sepsis syndrome consistently have a unimodal increase in the number of IL-1 R expressed on their surfaces with a normal Kd (Fig. 1) . IL-I R expression on PMN returns to normal within a few days after resolution of the sepsis syndrome (Fig. 2 ). An increase in expression of IL-1R on sepsis-PMN was demonstrated by three methods, including saturation curves of 1251I . i f ; t w i N K . ' ' L . . . leukocytosis appear not to be associated with increases in IL-1R, and active inflammatory processes such as systemic lupus erythematosus and rheumatoid arthritis may be accompanied by a decrease in expression of IL-IR on circulating PMN. We emphasize that more patients among various types of inflammatory processes must be studied before the actual sensitivity and specificity ofIL-IR expression on PMN can be established as the indicator for these diseases. The increased expression of IL-IR on circulating PMN during the sepsis syndrome surprised us in that we had originally hypothesized that PMN from these patients would have a decrease in expression of IL-1 R, because sepsis is often associated with circulation ofIL-1 as well as other cytokines such as TNFa (5, 6 , and reviewed in reference 25). Circulating IL-l would be expected to homologously down-regulate the IL-IR ofPMN, and circulation ofTNFa might reduce IL-lRby heterologous down-regulation. Indeed, we have found that homologous down-regulation of IL-1 occurs in vitro after stimulation of normal PMN with IL-1 (7) , and heterologous down-regulation ofIL-IR is induced by many stimuli, including endotoxin, FMLP, and TNFa (7, 26) . We cannot explain the apparent paradox of increased expression of IL-I R on sepsis-PMN. Although we do not know if the patients we studied had circulating IL-I or TNFa, elevations in plasma IL-I and TNFa would be expected in some of our patients.
The M, of IL-lR expressed on sepsis-PMN is the same as that found on normal PMN, further establishing that PMN express a lower M, form of IL-IR. At least two forms of IL-lR are expressed on cells (1, 27) . One has a M, of 80,000 (7, 8, 14, 15) and is found on T-cells and cells derived from mesenchyme, such as fibroblasts and synovial cells (9-13); another is a lower M, IL-IR (60,000-70,000) found on B cells, monocytes, and PMN (7, 8, 14, 15) . The high and low M, forms of IL-IR are now referred to as types 1 and 2 IL-IR, respectively, and they appear to be products of separate genes (14, 28 (13) .
Another surprising finding in this study is that the increased expression of IL-IR on sepsis-PMN is not associated with an increase in expression ofcomplement receptor CR3. Increased expression of CR3 has been reported on blood PMN obtained from patients with the inflammation ofbum injury (22, 23) , on PMN in exudates (29, 30) , and on blood PMN of patients with systemic lupus erythematosus (31). Although we observed no change in CR3 expression on sepsis-PMN, the increased expression of specific receptors on sepsis-PMN is not limited to IL-IR. We also have observed a unimodal increase in expression of the receptor for TNFa on sepsis-PMN in 11 of 11 patients with the sepsis syndrome (32); sepsis-PMN from these patients also had no change or a decrease in expression of the CR3 receptor. We have found that agents that enhance the expression of CR3 on normal PMN in vitro always concomitantly induce a rapid down-regulation of the IL-IR (26) . A somewhat analogous finding ofdiscordant expression ofreceptors on human PMN was reported for CSa and the receptors CR1, CR3, FcyR III, and FMLP (33) . Apparently, the expressions of IL-1, TNFa, and C5a receptors on PMN are under different controls than the other receptors, and up-regulation of some receptors may be associated with down-regulation of others.
We have not clearly identified the mechanism responsible for enhanced expression of IL-1 R on sepsis-PMN. Two anatomical sites might possibly regulate expression of IL-lR, the bone marrow and the peripheral circulation. Our data (Table  II) suggest that myeloid stimulation in the presence or absence of severe systemic inflammation is not a sufficient stimulus to induce up-regulation of IL-IR. Our finding that the IL-IR expression increases in normal PMN incubated with rhGM-CSF in vitro, and that this increase is inhibited by cycloheximide, suggests that enhanced expression of IL-IR on sepsis-PMN could depend on events that take place in the peripheral circulation and that require protein synthesis. However, it is unlikely that GM-CSF alone would be the agonist responsible for increased expression of IL-1 R, since the increase in number of IL-IR induced by rhGM-CSF on normal PMN was well below that found in sepsis-PMN and increases in circulating GM-CSF have not to our knowledge been reported in the sepsis syndrome. Other stimuli released during the sepsis syndrome, either alone or acting together, might amplify expression ofthe IL-IR gene. For example, Spriggs et al. recently reported that the steroid dexamethasone and prostaglandin E2 used together markedly enhance expression ofthe low Mr II-1 R expressed on human monocytic cells (34) . Dr. Spriggs has also found that stimulation of normal human PMN in vitro with dexamethasone and prostaglandin E2 causes a significant increase in the expression of IL-1 R (personal communication).
The functional responses of normal PMN to stimulation of IL-lR by IL-l appear to be tightly controlled. We (7, and unpublished observations) and others (35) have found that IL-1 stimulation of normal human PMN does not induce early responses of PMN such as NADPH oxidase-activation, degranulation, chemotaxis, translocation of protein kinase C, activation ofphospholipase C for phosphatidylinositol or phospholipase D for choline-containing phosphoglycerides, or increases in free intracellular calcium. However, IL-IR of normal PMN responds to stimulation by IL-I by inducing synthesis of both IL-la and P proteins (19, 36) , as well as TNFa (unpublished observations). We were unable to evaluate the function of the IL-lR on sepsis-PMN in this study because of limitations on blood procurement, so we do not know whether the increased expression of IL-R on sepsis-PMN is associated with an alteration in PMN responses which follow stimulation by IL-1.
In summary, the sepsis syndrome ofhumans is consistently associated with marked increases in the number of IL-IR expressed on circulating PMN, without a change in its M, or Kd.
The increase in IL-R is unimodally distributed on all sepsis-PMN. In contrast, sepsis-PMN have no increase in expression of CR3. Our limited study of other states ofinflammation and myeloid stimulation suggests that amplified expression of IL-IR on blood PMN might discriminate the sepsis syndrome from other diseases. The mechanism responsible for enhanced expression ofIL-1 R on sepsis-PMN is unknown, but we speculate that it follows an event or events which induce synthesis of IL-1R in PMN and that occurs, at least in part, in the peripheral circulation. The functional significance ofthis phenotypic change of PMN during the sepsis syndrome is unknown.
